DOI: 10.1055/s-00000105

Zentralblatt für Gynäkologie

LinksSchließen

Referenz

Jordan VC, Glusman JE, Powles TJ, Costa A. et al.
Incident primary breast cancer are reduced by raloxifene: integrated data from multicenter, double blind, randomized trials in 12 000 postmenopausal women. 
Breast Cancer Res Treat 1998; 50

Bibliographische Angaben herunterladen

Suchen in: